Effect of long-term clarithromycin antibiotic therapy on preventation of pneumonia in the elderly: a prospective randomised controlled trial.

Effect of long-term clarithromycin antibiotic therapy on preventation of pneumonia in the elderly: a prospective randomised controlled trial. - Effect of long-term clarithromycin antibiotic therapy on preventation of pneumonia in the elderly: a prospective randomised controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023355

Enrollment

200

Registered

2016-08-01

Start date

2016-12-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia

Interventions

administration of clarithromycin, 200mg/day, 1 year control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients 65 years of age and older 2) Patients who has the past of pneumonia

Exclusion criteria

Exclusion criteria: 1) Patients under 65 years old 2) Patients with a history of the past of hypersensitivity for an ingredient of the clarithromycin 3) Patients having serious complications 4) Patients who is taking the drug that blood levels changes by clarithromycin 5) Patients who is already giving antimicrobial including the macrolide 6) Patients having nontuberculous acid-fast bacterial disease 7) Patients who judged the physician to be inappropriate for this study

Design outcomes

Primary

Measure	Time frame
Frequency of pneumonia	—

Secondary

Measure	Time frame
TTime to pneumonia recurrence	—

Countries

Japan

Contacts

Public ContactMari Yamasue

Oita University Faculty of Medicine Department of Respiratory Medicine and Infectious Diseases

sai-mari@oita-u.ac.jp097-549-4411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026